An analysis of the efficiency of a Rhesus haemolytic disease prophylaxis programme.
D036861:Delivery, Obstetric; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005069:Evaluation Studies as Topic; D005260:Female; D005313:Fetal Death; D006760:Hospitalization; D006801:Humans; D007116:Immunization, Passive; D007231:Infant, Newborn; D007518:Isoantibodies / Q000008:administration & dosage*; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System / Q000032:analysis; D013048:Specimen Handling; D013997:Time Factors; D014470:Umbilical Cord
D007518:Isoantibodies; D012204:Rh-Hr Blood-Group System